Orionis Biosciences

Waltham, United States

Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.

$55.0M raised

Oct 2022

Series C

Biotechnology Health Care Health Diagnostics Medical

Top Investors

Novartis Cormorant Asset Management V-Bio Ventures Empire Angels Excel Venture Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Orionis Biosciences

How much funding has Orionis Biosciences raised?

Orionis Biosciences has raised $55.0M in total funding. The most recent round was Series C. The last funding was announced in October 2022.

Who are Orionis Biosciences's investors?

Orionis Biosciences's investors include Novartis, Cormorant Asset Management, V-Bio Ventures, Empire Angels, Excel Venture Management.

Where is Orionis Biosciences headquartered?

Orionis Biosciences is headquartered in Waltham, United States.

What does Orionis Biosciences do?

Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.

What stage is Orionis Biosciences at?

Orionis Biosciences is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 19, 2022.

MLA

"Orionis Biosciences — Funding & Investors." VCBacked, October 19, 2022, https://www.vcbacked.co/company/orionis-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2022). Orionis Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/orionis-biosciences

Wikipedia (cite web)

{{cite web |title=Orionis Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/orionis-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 19, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K